跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GRUMABIX 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
GRUMABIX 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
GRUMABIX 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Adamed Pharma S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 21, 2022
Approval ID
e474f8a1902d0510
Company
Adamed Pharma S.A.
Type
Standard
Approval Details
Approval Id
e474f8a1902d0510
Drug Cima Aemps Name
GRUMABIX 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
86576
Holder Company Name
Adamed Pharma S.A.
Marketing Company Name
Adamed Pharma S.A.
Holder Company Detail Path
/organization/adamed-pharma-s-a
Marketing Company Detail Path
/organization/adamed-pharma-s-a
Authorization Date
2022-02-21
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
250 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Adamed Pharma S.A.
Company Detail Path
/organization/adamed-pharma-s-a
Company Information
Pharmaceutical Company Name
Adamed Pharma S.A.
Country Name
Poland
Website
https://www.adamed.com/
Active Ingredients
ABIRATERONA ACETATO
250 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 21, 2022
Approval ID
e474f8a1902d0510
Type
Standard
Back to CIMA-AEMPS Approvals